SeroTracker: a global SARS-CoV-2 seroprevalence dashboard - 25/03/21
Doi : 10.1016/S1473-3099(20)30631-9
Rahul K Arora a, c 
, Abel Joseph e, Jordan Van Wyk e, Simona Rocco e, Austin Atmaja e, Ewan May c, d, Tingting Yan f, g, Niklas Bobrovitz b, f, Jonathan Chevrier h, Matthew P Cheng i, Tyler Williamson c, David L Buckeridge h
, Abel Joseph e, Jordan Van Wyk e, Simona Rocco e, Austin Atmaja e, Ewan May c, d, Tingting Yan f, g, Niklas Bobrovitz b, f, Jonathan Chevrier h, Matthew P Cheng i, Tyler Williamson c, David L Buckeridge h a Institute of Biomedical Engineering, University of Oxford, Oxford OX3 7DQ, UK
b Centre for Evidence-Based Medicine, University of Oxford, Oxford OX3 7DQ, UK
c Centre for Health Informatics, Cumming School of Medicine, University of Calgary, AB, Canada
d Schulich School of Engineering, University of Calgary, AB, Canada
e Faculty of Engineering, University of Waterloo, Waterloo, ON, Canada
f Faculty of Medicine, University of Toronto, Toronto, ON, Canada
g Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
h Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montreal, QC, Canada
i McGill Interdisciplinary Initiative in Infection and Immunity, Faculty of Medicine, McGill University, Montreal, QC, Canada
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2021
Elsevier Ltd. Tous droits réservés.
Vol 21 - N° 4
P. e75-e76 - avril 2021 Retour au numéro
Article précédent
- Excess mortality from COVID-19 in an English sentinel network population
- Mark Joy, F D Richard Hobbs, Dylan McGagh, Oluwafunmi Akinyemi, Simon de Lusignan
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
- Fabian Standl, Karl-Heinz Jöckel, Bastian Brune, Börge Schmidt, Andreas Stang
Bienvenue sur EM-consulte, la référence des professionnels de santé.